JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clarke, J. T. R.
Right arrow Articles by Perlin, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clarke, J. T. R.
Right arrow Articles by Perlin, A. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Evidence for a Terminal agr-d-Galactopyranosyl Residue in Galactosylgalactosylglucosylceramide from Human Kidney

J. T. R. Clarke 1, L. S. Wolfe 1, and A. S. Perlin 2

From the 1 From the Donner Laboratory of Experimental Neurochemistry, Montreal Neurological Institute, Montreal 112, Canada
2 From the Department of Chemistry, McGill University, Montreal 110, Canada

Galactosylgalactosylglucosylceramide (CTH) was extracted and purified from pooled normal human kidney tissue and also from the kidney of a patient with Fabry's disease, a glycosphingolipid storage disease characterized by a defect in the catabolism of CTH. Nuclear magnetic resonance spectra of the intact molecules were recorded at 100 and 220 MHz in pyridine-d5 at various temperatures. The characteristics of signals attributable to the anomeric protons are consistent with the following structural features: a ß-d-glucopyranosyl residue linked to ceramide (H-1, doublet, dgr = 4.74 ppm, J = 7.6 Hz);an internal, ß-d-galactopyranosyl residue (H-1, doublet, dgr = 4.94 ppm, J = 7.5 Hz);a terminal agr-d-galactopyranosyl residue (H-1, doublet, dgr = 5.45 ppm, J = 4.1 Hz). Optical rotatory data are also consistent with such a formulation for the glycolipid. CTH and lactosylceramide labeled in the terminal d-galactosyl moiety were prepared by oxidation with the enzyme d-galactose oxidase (EC 1.1.3.-) and reduction of the resulting hexodialdoses with [3H]NaBH4. With the use of these substrates, it was found that the terminal d-galactosidic linkage of CTH, but not of lactosylceramide, was hydrolyzed by partially purified agr-d-galactoside galactohydrolase (EC 3.2.1.22) from green coffee beans. These physicochemical and enzymic data are presented as proof that the terminal d-galactopyranosyl residue of the CTH of human renal tissue has the agr stereoconfiguration.

Submitted on April 8, 1971


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1971 by the American Society for Biochemistry and Molecular Biology.